News › Clinical Practice, Industry News, Patient Care

Botulinum and the Brow

May 24, 2019

The extent that brows descend after botulinum toxin injections is greatly influenced by the amount of frontalis weakening, according to a small study by German researchers published May 2019 in the Aesthetic Surgery Journal.German researchers used three-dimensional (3D) technology to evaluate eyebrow position after treatment with abobotulinumtoxinA (Azzalure, Galderma). They studied two groups of adult women: one group received glabella-only injections; the other received glabella plus frontalis muscle injections. Researchers measured brow position pre-injection and at 2 weeks, 3 months and 6 months post injection.
Read more at Dermatology Times >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Merz Aesthetics’ Radiesse Receives FDA Approval for Décolleté Wrinkles
    • New Book “Get Found, Get Booked” Reveals a Smarter, Ethical Approach to Marketing for Med Spas and Wellness Practices
    • Growth, Capital and Control: Navigating Private Equity in Aesthetics
    • Med Spas Under the Microscope – The View From The FDA
    • Revance and Teoxane Announce RHA Dynamic Volume is Now Available